About Acinta Pharmaceuticals Private Limited
Data last updated:
Acinta Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2010PTC201377. Its GSTIN is 27AAICA3315M1ZL (Maharashtra). The company holds 8 GST registrations, of which 6 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yash Sharma (Whole-Time Director) and Praveen Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 141 Atlanta 14th Floor Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.54 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹1.14 Cr (net margin -6.1%) and EBITDA of -₹1.14 Cr (EBITDA margin -6.1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 4% over five years.
The company has about 167 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Acinta. Court records list 3 cases involving the company, including 3 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acintapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address141 Atlanta 14th Floor Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Acinta Pharmaceuticals Private Limited
The main business activity of Acinta Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Acinta Pharmaceuticals Private Limited FY 2025 filings available
Acinta Pharmaceuticals Private Limited reported revenue of ₹18.54 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Acinta Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 2% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Acinta Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.14 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.14 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Acinta Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -6.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acinta Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aakash Pharma Private Limited | ₹18.62 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Madurai, Tamil Nadu, India |
| Sai Sarvaa Biotech Private Limited | ₹18.57 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Villupuram, Tamil Nadu, India |
| Cornel Pharmaceuticals Private Limited | ₹18.56 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| One Drip Healthcare Private Limited | ₹18.55 Cr (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Koye Lifesciences Private Limited | ₹18.55 Cr (FY 2025) | •••• | •••• | 52.0% | •••• | Mumbai, Maharashtra, India |
| Acinta Pharmaceuticals Private Limited this company | ₹18.54 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Mannequin Pharmaceuticals Private Limited | ₹18.54 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Bhubaneswar, Odisha, India |
| Megasys Biotek Private Limited | ₹18.53 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Thrissur, Kerala, India |
| Hind Chemicals Limited | ₹18.5 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Uttar Pradesh, India |
| Nutriva Lifesciences Private Limited | ₹18.5 Cr (FY 2024) | •••• | •••• | 50.0% | •••• | Mumbai, Maharashtra, India |
| Mba Pharmaceuticals Private Limited | ₹18.48 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Acinta Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals Private Limited is audited by K.M.SWADIA & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K.M.SWADIA & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Sharma | Director | 29 Mar 2010 | 16 Years 6 Months | Current |
| Meenakshi Sharma Also directs: Angola Diamond Private Limited, Sez Developers Association of India, Jaipur Gemstone Exchange and 3 more | Director | 25 Jun 2012 | 14 Years 3 Months | Current |
| Yash Sharma | Whole-Time Director | 23 Jul 2019 | 7 Years 2 Months | Current |
Ownership and Shareholding of Acinta Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals Private Limited has 3 court cases on record: 3 filed by Acinta Pharmaceuticals. 1 case is pending and 2 are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against individuals | Pending |
| District court, Ranchi, Jharkhand | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against Medicald Enterprises Others | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals operates one associated brand: ACINTA. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and marketing services in India. | acintapharma.com |
Employees and EPFO Compliance at Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals Private Limited has a workforce of 167 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals Private Limited has 7 board changes on record since 2010: 5 appointments and 2 cessations. The latest: Sanjay Vidyanand Sharma ceased to be Director on 23 Jul 2019.
Credit Ratings, Litigation & Regulatory Alerts for Acinta Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acinta Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acinta Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals has 8 GST registrations: 6 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICA3315M1ZL | Maharashtra | Active | 01 Jul 2017 |
| 05AAICA3315M1ZR | Uttarakhand | Active | 01 Jul 2017 |
| 08AAICA3315M1ZL | Rajasthan | Active | 01 Jul 2017 |
| 18AAICA3315M1ZK | Assam | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acinta Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acinta Pharmaceuticals Private Limited
Acinta Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 March 2010 (16+ years old) and is registered under CIN U24233MH2010PTC201377.
Acinta Pharmaceuticals reported revenue of ₹18.54 Cr for FY 2025 (up 2% YoY).
Acinta Pharmaceuticals has 3 current directors:
- Yash Sharma - Whole-Time Director
- Praveen Sharma - Director
- Meenakshi Sharma - Director
Acinta Pharmaceuticals reported a net loss of ₹1.14 Cr (net margin -6.1%) and EBITDA of -₹1.14 Cr (EBITDA margin -6.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Acinta Pharmaceuticals is 9% over three years and 4% over five years. In the latest year (FY 2025) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Acinta Pharmaceuticals is 27AAICA3315M1ZL, registered in Maharashtra. The company has 8 GST registrations in all, of which 6 are active and 2 are cancelled or inactive. Other active GSTINs include 05AAICA3315M1ZR (Uttarakhand), 08AAICA3315M1ZL (Rajasthan), 18AAICA3315M1ZK (Assam).
The CIN (Corporate Identification Number) of Acinta Pharmaceuticals is U24233MH2010PTC201377. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acinta Pharmaceuticals has 3 court cases on record: 3 filed by the company. 1 is pending.
Acinta Pharmaceuticals was incorporated on 29 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Acinta Pharmaceuticals by revenue are Aakash Pharma Private Limited, Sai Sarvaa Biotech Private Limited, Cornel Pharmaceuticals Private Limited, One Drip Healthcare Private Limited, Koye Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sanjay Vidyanand Sharma ceased to be Director on 23 Jul 2019. Yash Sharma was appointed as Whole-Time Director on 23 Jul 2019. Sanjay Vidyanand Sharma was appointed as Director on 03 Mar 2014. Acinta Pharmaceuticals has 7 board changes on record in total.